C5-Modified nucleosides exhibiting anticancer activity

Cited 67 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorY S Lee-
dc.contributor.authorS M Park-
dc.contributor.authorHwan Mook Kim-
dc.contributor.authorSong Kyu Park-
dc.contributor.authorKiho Lee-
dc.contributor.authorChang Woo Lee-
dc.contributor.authorB H Kim-
dc.date.accessioned2017-04-19T09:14:14Z-
dc.date.available2017-04-19T09:14:14Z-
dc.date.issued2009-
dc.identifier.issn0960-894X-
dc.identifier.uri10.1016/j.bmcl.2009.06.072ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/9061-
dc.description.abstractWe describe (i) a simple method for the synthesis of C5-modified nucleosides from 5-iodo-20-deoxyuridine and (ii) their activity against six types of human cancer cell lines (HCT15, MM231, NCI-H23, NUGC-3, PC-3, ACHN). We generated nitrile oxides in situ from oximes using a commercial bleaching agent; their cycloadditions with 5-ethynyl-20-deoxyuridine yielded isoxazole derivatives possessing activity against the cancer cell lines. We synthesized several azides from benzylic bromides and their click reactions with 5-ethynyl-20-deoxyuridine provided triazole derivatives.-
dc.publisherElsevier-
dc.titleC5-Modified nucleosides exhibiting anticancer activity-
dc.title.alternativeC5-Modified nucleosides exhibiting anticancer activity-
dc.typeArticle-
dc.citation.titleBioorganic & Medicinal Chemistry Letters-
dc.citation.number16-
dc.citation.endPage4691-
dc.citation.startPage4688-
dc.citation.volume19-
dc.contributor.affiliatedAuthorHwan Mook Kim-
dc.contributor.affiliatedAuthorSong Kyu Park-
dc.contributor.affiliatedAuthorKiho Lee-
dc.contributor.affiliatedAuthorChang Woo Lee-
dc.contributor.alternativeName이윤석-
dc.contributor.alternativeName박선민-
dc.contributor.alternativeName김환묵-
dc.contributor.alternativeName박성규-
dc.contributor.alternativeName이기호-
dc.contributor.alternativeName이창우-
dc.contributor.alternativeName김병현-
dc.identifier.bibliographicCitationBioorganic & Medicinal Chemistry Letters, vol. 19, no. 16, pp. 4688-4691-
dc.identifier.doi10.1016/j.bmcl.2009.06.072-
dc.subject.keywordAnticancer-
dc.subject.keywordNucleoside-
dc.subject.keywordTriazole-
dc.subject.keywordIsoxazole-
dc.subject.keywordCycloaddition-
dc.subject.localAnti-cancer-
dc.subject.localAnticancer-
dc.subject.localanti-cancer-
dc.subject.localanticancer-
dc.subject.localAnti-Cancer-
dc.subject.localNucleoside-
dc.subject.localTriazole-
dc.subject.localtriazole.-
dc.subject.localtriazole-
dc.subject.localIsoxazole-
dc.subject.localisoxazole-
dc.subject.localCycloaddition-
dc.description.journalClassY-
Appears in Collections:
Ochang Branch Institute > Division of National Bio-Infrastructure > Laboratory Animal Resource & Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.